Translate Bio, Inc. Business Finance Contracts & Agreements
13 Contracts & Agreements
- Indenture Agreements (1 contract)
- Purchase Agreements (4)
- Registration Rights Agreements (3)
- Stock Agreements (2)
- Underwriting Agreements (3)
- Indenture of Lease, dated November 3, 2020, by and between the Registrant and Boston Properties Limited Partnership (Filed With SEC on March 1, 2021)
- Registration Rights Agreement, dated July 20, 2020, by and between the Registrant and Sanofi, a French corporation (Filed With SEC on August 6, 2020)
- Securities Purchase Agreement, dated June 22, 2020, by and between the Registrant and Sanofi, a French corporation (Filed With SEC on August 6, 2020)
- Underwriting Agreement, dated June 25, 2020, by and among the Company, Goldman Sachs and Co. LLC, SVB Leerink LLC, Evercore Group L.L.C. and the selling stockholder of the Company... (Filed With SEC on June 26, 2020)
- Underwriting Agreement, dated September 17, 2019, by and among the Company and Citigroup Global Markets Inc., Jefferies LLC and SVB Leerink LLC (Filed With SEC on September 18, 2019)
- Registration Rights Agreement, dated April 30, 2019, by and among the Registrant and the other parties thereto (Filed With SEC on May 1, 2019)
- Securities Purchase Agreement, dated April 30, 2019, by and among the Registrant and the other parties thereto (Filed With SEC on May 1, 2019)
- First Amendment to Asset Purchase Agreement, by and between the Registrant and Shire Human Genetic Therapies, Inc., dated as of June 7, 2018 (Filed With SEC on June 12, 2018)
- Form of Underwriting Agreement (Filed With SEC on June 12, 2018)
- 2018 Employee Stock Purchase Plan (Filed With SEC on June 1, 2018)
- Amended and Restated Registration Rights Agreement, by and among the Registrant and the other parties thereto, dated as of December 22, 2016 (Filed With SEC on June 1, 2018)
- Specimen Stock Certificate evidencing the shares of common stock (Filed With SEC on June 1, 2018)
- Asset Purchase Agreement, by and between the Registrant and Shire Human Genetic Therapies, Inc., dated as of December 22, 2016 (Filed With SEC on June 1, 2018)
